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Summary
Protein microbicides containing neutralizing antibodies and antiviral lectins may help to reduce
the rate of infection with human immunodeficiency virus (HIV) if it is possible to manufacture the
components in large quantities at a cost affordable in HIV-endemic regions such as sub-Saharan
Africa. We expressed the antiviral lectin griffithsin (GRFT), which shows potent neutralizing
activity against HIV, in the endosperm of transgenic rice plants (Oryza sativa), to determine
whether rice can be used to produce inexpensive GRFT as a microbicide ingredient. The yield of
OSGRFT in the best-performing plants was 223 lg/g dry seed weight. We also established a one-
step purification protocol, achieving a recovery of 74% and a purity of 80%, which potentially
could be developed into a larger-scale process to facilitate inexpensive downstream processing.
OSGRFT bound to HIV glycans with similar efficiency to GRFT produced in Escherichia coli. Whole-
cell assays using purified OSGRFT and infectivity assays using crude extracts of transgenic rice
endosperm confirmed that both crude and pure OSGRFT showed potent activity against HIV and
the crude extracts were not toxic towards human cell lines, suggesting they could be
administered as a microbicide with only minimal processing. A freedom-to-operate analysis
confirmed that GRFT produced in rice is suitable for commercial development, and an economic
evaluation suggested that 1.8 kg/ha of pure GRFT could be produced from rice seeds. Our data
therefore indicate that rice could be developed as an inexpensive production platform for GRFT
as a microbicide component.
Introduction
The rate of infection caused by human immunodeficiency virus
(HIV) is declining, but the HIV+ population reached an estimated
35 million in 2013 and there were 2.1 million new cases
(UNAIDS, 2014). The availability and effectiveness of antiretroviral
therapy is also increasing, which means that the HIV+ population
is living longer (Abdool Karim and Baxter, 2012; Lynch et al.,
2012). However, the burden of the disease falls disproportion-
ately on sub-Saharan Africa, which accounts for more than 70%
of global cases. Here, 1 in 20 people is HIV+ and up to 22 million
have no access to life-saving treatments (UNAIDS, 2014).
HIV infections cannot currently be cured, but there is a
window of opportunity lasting 30–60 min between exposure
and infection during which pre-exposure prophylaxis can block
the uptake of the virus (Shattock and Rosenberg, 2012). When
the virus interacts with mucosal tissue, an infection is established
within 16–72 h (Haase, 2011). Topical microbicides represent a
subset of pre-exposure prophylaxis strategies and are classified
according to their target and mechanism of action. Surfactants
kill the pathogen, replication inhibitors prevent virus replication,
buffers enhance the vaginal milieu of protectors, and entry/
fusion inhibitors block virus entry into host cells (McGowan,
2006).
Entry inhibitors can bind sites on the virus or its cellular
receptors (CD4, CCR5 or CXCR4) to prevent virus–cell interac-
tions. Some entry inhibitors are anionic polymers or polyanions,
for example cellulose sulphate, PRO-2000, dextrin sulphate,
SPL7013, Carraguard, SAMMA and cellulose acetate phthalate.
Although proven to be safe and well tolerated, these have failed
to provide protection against HIV-1 in clinical trials (El-Sadr et al.,
2006; Joshi et al., 2006; McCormack et al., 2005; Patton et al.,
2006). Other more specific microbicides such as CCR5 inhibitors,
for example PSC-RANTES (Kawamura et al., 2003), and fusion
inhibitors, such as the lectins griffithsin (GRFT) and cyanovirin-N
(CV-N), demonstrate picomolar range IC50 values against all HIV-1
clades but have yet to be tested in clinical trials (Ramessar et al.,
2010).
GRFT is a 12.7 kDa lectin isolated from the red alga Griffithsia
spp. (Mori et al., 2005). It inhibits HIV-1 by binding selectively to
mannose-rich glycans on the virus envelope glycoproteins
(Balzarini, 2005; Mori et al., 2005) and has demonstrated
broad-spectrum antiviral activity against severe acute respiratory
syndrome-associated coronavirus (SARS-CoV) and other coron-
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aviruses (O’Keefe et al., 2010; Ziołkowska et al., 2006), hepatitis
C virus (Meuleman et al., 2011; Takebe et al., 2013), Japanese
encephalitis virus (Ishag et al., 2013) and herpes simplex virus
(Nixon et al., 2013). GRFT has no mitogenic effect on peripheral
blood mononuclear cells, but shows full activity in the presence of
macaque vaginal secretions (Emau et al., 2007) and has a good
safety profile in the rabbit vaginal irritation model (O’Keefe et al.,
2009). GRFT can also inhibit HIV-1 binding to the dendritic cell-
specific intercellular adhesion molecule-3-grabbing nonintegrin
(DC-SIGN) and prevents DC-SIGN-mediated transfer of the virus
to target cells (Alexandre et al., 2010).
Only small quantities of GRFT can be isolated from algae so the
development of lectin-based microbicides requires the expression
of recombinant lectins in larger amounts. GRFT has been
expressed as a recombinant protein in Escherichia coli (Giomarelli
et al., 2006) and in Nicotiana benthamiana (O’Keefe et al., 2009)
despite concerns that the production of recombinant lectins in
plants might interfere with signalling processes and plant
development (Lotter-Stark et al., 2012). The yield of recombinant
GRFT in E. coli (ECGRFT) was 819 mg per litre of culture medium
but 33% of the protein accumulated as inclusion bodies and was
therefore misfolded and nonfunctional (Giomarelli et al., 2006).
In contrast, the transient expression of GRFT in N. benthamiana
using a vector based on tobacco mosaic virus (TMV) resulted in
the production of up to 1 g of soluble GRFT per kg of fresh leaf
weight (O’Keefe et al., 2009). Even so, the transient expression of
microbicides in leafy crops has several drawbacks, including the
need to process the tissue immediately after harvest to prevent
protein degradation, and the need for complete purification due
to the presence of toxic metabolites in tobacco and endotoxins
produced by the infiltrating bacteria (Arfi et al., 2015).
Transgenic seeds are advantageous because they can be stored
for long periods under ambient conditions without recombinant
proteins losing stability, and the generally regarded as safe
(GRAS) status of cereal seeds means that microbicides could be
administered as crude extracts rather than reformulated pure
proteins, thus reducing production costs substantially (Peters and
St€oger, 2011; Ramessar et al., 2008a; Sabalza et al., 2013). We
therefore generated transgenic rice plants expressing GRFT in the
endosperm and tested both the pure protein and crude extracts
for their HIV-specific binding activity and ability to neutralize HIV
in vitro. Our studies were complemented with a griffithsin-specific
freedom-to-operate (FTO) analysis and a preliminary techno-
economic evaluation, which are essential first steps towards
product development and commercialization.
Results
GRFT is expressed in T1 transgenic rice endosperm and is
correctly folded in planta
Mature seed-derived rice embryos (15–20 days after pollination)
were transformed by particle bombardment with a construct
containing the GRFT coding sequence under the control of the
maize zein promoter and a second construct containing the
selectable marker hpt (Christou et al., 1991). Embryo-derived
callus was selected on hygromycin-supplemented medium and 13
independent transformants were regenerated and transferred to
the greenhouse. We chose three independent lines (2, 6 and 10)
that expressed OSGRFT at high levels in the endosperm (128, 301
and 104 lg/g dry seed weight, respectively). The yields were
determined by enzyme-linked immunosorbent assay (ELISA) to
ensure that we detected only the correctly folded and soluble
form of the protein. The remaining lines expressed OSGRFT at only
low levels and thus were deemed unsuitable for further exper-
iments. The best-performing line (line 6) was selected for further
in-depth investigation (Figure 1a).
A one-step protocol allows the inexpensive purification
of OSGRFT
The OSGRFT protein was purified from crude extracts of T1 rice
endosperm prepared from line 6 by capturing the protein on an
immobilized metal affinity chromatography (IMAC) column and
eluting it with buffer containing 250 mM imidazole. The final yield
of OSGRFT after purification was 223 lg/g dry seed weight, which
represents a recovery of 74%. The presence of OSGRFT in the
crude extracts was confirmed by reducing sodium dodecyl
sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) followed
by staining with Coomassie Brilliant Blue, showing a visible band
of ~15 kDa, the anticipated molecular mass of His6-tagged GRFT
(Figure 2a). The presence of OSGRFT was confirmed by
immunoblotting and detection using a primary rabbit anti-GRFT
Figure 1 (a) GRFT accumulation in rice endosperm. An immunoglobulin-
specific sandwich ELISA was used to screen the three best-performing
independent events. The ELISA plate was coated with gp120, and GRFT
protein assembly was confirmed using a primary rabbit anti-GRFT
polyclonal antiserum and a secondary HRP-conjugated anti-rabbit IgG
antiserum. Four serial dilutions per sample are shown (neat, 1/2, 1/4 and 1/
8). WT, wild-type extracts; C, negative control (PBS); C+, GRFT purified
from E. coli (500 ng/mL) as a positive control. OD, optical density at
450 nm. (b) Transformation construct pgZ63-GRFT for the stable
expression of GRFT in rice endosperm. The expression cassette comprised
the endosperm-specific maize zein promoter, the rice a-amylase 3A signal
peptide sequence (SP), a His6 tag, the GRFT coding region (grft) and the
nos terminator (t-nos).
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polyclonal antiserum (Figure 2b). This revealed an intense band at
14.6 kDa, the correct size for His6-tagged GRFT, and another at
16–17 kDa probably representing the incomplete removal of the
rice a-amylase (RAmy3D) signal peptide which is 25 residues in
length and has a predicted molecular mass of 2.6 kDa. Alterna-
tively, the additional band may reflect O-linked glycosylation at
one of the multiple serine or threonine residues of GRFT. No
degradation products were present, suggesting the protein
remained stable in the rice endosperm tissue (Figure 2b).
Crude rice endosperm extracts containing OSGRFT show
gp120-binding activity comparable to pure ECGRFT
The crude extracts from T1 seeds of transgenic lines 2, 6 and 10
were tested by ELISA for in vitro binding activity against HIV
gp120, using ECGRFT as a positive control and wild-type rice
endosperm as a negative control. Extracts from all three trans-
genic lines showed greater gp120-binding activity than the wild-
type endosperm extracts as expected, which confirmed that the
OSGRFT was functional and that endogenous plant lectins do not
interfere with binding. Furthermore, crude endosperm extracts
containing OSGRFT bound to gp120 in a concentration-depen-
dent manner, with binding behaviour nearly identical to that of
ECGRFT. The crude extracts containing OSGRFT therefore pos-
sessed essentially the same oligosaccharide-dependent binding
properties as the same recombinant protein expressed in bacteria
(Figure 3).
OSGRFT accumulates to high levels in rice endosperm
protein bodies
Fluorescence microscopy and transmission electron microscopy
(TEM) were used to study the localization of OSGRFT in the
endosperm of developing seeds from line 6. The deposition of
OSGRFT was investigated in the young endosperm cells immedi-
ately under the aleurone layer, which are packed with starch
grains, as well as storage organelles which show a strong labelling
for GRFT (Figure 4a,b). No significant labelling was detected in
any other compartment of the endosperm cells, the apoplast or
the aleurone cells (Figure 4b). TEM imaging confirmed the
deposition of GRFT in the protein storage vacuole (PSV), also
known as type II protein bodies (PB-II), whereas there was no
significant labelling in the ER-derived prolamin bodies, also
known as type I protein bodies (PB-I) (Figure 4c).
Crude extracts containing OSGRFT and purified OSGRFT
show potent neutralizing activity against HIV in whole-
cell and infectivity assays but no toxicity towards human
cells
We next tested purified OSGRFT and ECGRFT head to head in
whole-cell HIV neutralization assays. As expected from their
similar in vitro binding behaviour, both proteins achieved similar
EC50 values in the nanomolar range: 0.27 nM for
OSGRFT
(Figure 5a) and 0.33 nM for ECGRFT (Figure 5b). The wild-type
crude extract showed no activity against HIV in the whole-cell
assay, although it did cause a general increase in cell growth in
Figure 2 (a) Separation of the purified GRFT fraction by SDS-PAGE under
reducing conditions showing the 14.6 kDa band representing GRFT
(arrow). M = Precision Plus ProteinTM All Blue Standards (Bio-Rad), lane
A = 3.5 lg GRFT and lane B = 3.8 lg of GRFT protein. (b) Analysis of
OSGRFT by SDS-PAGE under reducing conditions and immunoblotting
using a primary rabbit anti-GRFT polyclonal antiserum and a secondary
HRP-conjugated anti-rabbit IgG. C+ = positive control (50 ng ECGRFT),
M = protein size marker Precision Plus ProteinTM All Blue Standards (Bio-
Rad). The arrow shows the anticipated size of the GRFT-His6 protein.
Figure 3 Antigen-binding activity of crude rice endosperm extracts
containing OSGRFT and the purified ECGRFT determined by ELISA.
Ordinate: Optical density at 450 nm. Abscissa: Serial dilutions. Values are
the average of two experiments  SE. Plates coated with HIV-1 gp120
were tested with different concentrations of crude extracts or fixed
concentrations of purified GRFT from E. coli, and binding activity was
measured using a primary rabbit anti-GRFT polyclonal antiserum and a
secondary HRP-conjugated anti-rabbit IgG. WT, wild-type plants; C,
negative control (PBS); C+, ECGRFT (concentration 500 ng/mL) as a positive
control; 2, 6, 10, independent events expressing OSGRFT; OD, optical
density at 450 nm.
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both controls and virus-challenged cells in culture, confirming
that native rice lectins do not possess HIV-neutralizing activity
(Figure 5c). Infectivity assays confirmed the potent antiviral
activity of crude extracts containing OSGRFT. Crude extracts of
wild-type rice endosperm also showed a low level of viral
inhibition, perhaps due to the presence of a protein/polysaccha-
ride milieu that delays contact between the virus and the target
cells (Figure 6a). Crude extracts of rice endosperm containing
OSGRFT at dilutions of 1/4 and higher showed no significant
cytotoxicity against the cell line, indicating that microbicides
prepared with crude extracts are unlikely to be harmful when
used for topical application (Figure 6b).
Discussion
Griffithsin (GRFT) is a lectin isolated from the red alga Griffithsia
spp. that binds to high mannose oligosaccharides displayed on
the envelope glycoproteins of many different viruses (Xue et al.,
2013) including HIV (Ziołkowska et al., 2007a). GRFT is active
against HIV clades A, B and C, which are predominant in sub-
Saharan Africa, India and the west (Lotter-Stark et al., 2012), and
is equally active against T-tropic and M-tropic strains of HIV-1
(Mori et al., 2005). GRFT acts as an HIV entry inhibitor, blocking
virus–cell fusion at subnanomolar concentrations and reducing
the cytopathic effect of laboratory strains and clinical primary
isolates of HIV-1 at picomolar concentrations (Mori et al., 2005).
Native GRFT can be purified directly from its source but only in
minute quantities (Mori et al., 2005). The production of recom-
binant GRFT is therefore necessary to meet the demand for this
protein as a microbicide component. GRFT has been produced in
E. coli with a yield of 819 mg/l, but only 66% of the protein was
present in the soluble fraction and the remainder was found in
inclusion bodies and was impossible to resolubilize even using
detergents (Giomarelli et al., 2006). O’Keefe et al. (2009)
addressed this challenge by producing soluble GRFT in N. ben-
thamiana leaves using a vector based on TMV, achieving a yield of
1 mg/g leaf tissue, which was reduced to 0.3 mg/g after
purification, representing a recovery of 30%.
We investigated the use of rice endosperm as an alternative
production platform for recombinant GRFT because rice has a
number of application-specific advantages over leafy crops in the
context of microbicides. Like other seed-based platforms, the
recombinant protein accumulates in dry seeds and can be stored
indefinitely under ambient conditions, whereas tobacco leaves
must be processed immediately after harvesting to avoid protein
degradation (Ramessar et al., 2008a; Sabalza et al., 2013).
Furthermore, rice has GRAS status and has been developed as a
production platform for proteins that can be administered in
minimally processed seed, such as oral vaccines and prophylactics
(An et al., 2013; He et al., 2011; Ning et al., 2008; Vamvaka
et al., 2015; Xie et al., 2008; Zhang et al., 2012), whereas
proteins transiently expressed in tobacco must be purified to
remove toxic metabolites (Obembe et al., 2011) and the bacterial
endotoxins produced during agroinfiltration (Arfi et al., 2015).
We created transgenic rice plants expressing GRFT under the
control of an endosperm-specific promoter and recovered 13
independent transgenic events, three of which were selected for
further investigation because they produced T1 seeds in numbers
sufficient for analysis. This is the first time that GRFT has been
expressed in stably transformed plants and the first time it has
been expressed in cereal seeds. Line 6 was selected for additional
(a)
(b)
(c)
Figure 4 Localization of OSGRFT in immature rice seeds, 15–20 days after
pollination. (a) Interference contrast microscopy. (b) Fluorescence
microscopy. The outlined area in (a) is shown as an inset panel in (b) with
merged channels. (c) Immuno-electron microscopy. Outlined area is
shown enlarged twofold along each axis in the inset panel. Arrowheads in
(a) and (b) represent storage organelles. Abbreviations: SG, starch granule;
AL, aleurone layer; PRO, protein body; PSV, protein storage vacuole.
Bars = 5 lm (a, b, including inset panel), 0.5 lm (c).
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experiments because T1 seeds produced the highest yields of
OSGRFT (301 lg/g dry seed weight). GRFT has been produced at
higher levels by transient expression in N. benthamiana (1 mg/g
after 12 days), but this was reduced to 300 lg/g after purifica-
tion, which is only slightly higher than our yields of pure protein
(223 lg/g dry seed weight) and similar to the yield of 350 lg/g
reported for another lectin (CV-N) produced in transgenic
soybean (O᾽Keefe et al., 2015). It is also likely that our T1 yields
can be improved further by breeding line 6 to homozygosity, as
demonstrated for other recombinant proteins produced in cereal
seeds (Hood et al., 2012). For example, the monoclonal antibody
2G12 was expressed in rice seeds with a yield of 37 lg/g in the T1
generation but this increased to 46 lg/g in the T3 generation
after two rounds of self-pollination (Vamvaka et al., 2015).
Furthermore, 2G12 was expressed in maize seeds with a yield of
75 lg/g, which was increased to 100 lg/g by passaging the
transgenic plants through a dedifferentiation–differentiation cycle
(Ramessar et al., 2008b).
Figure 5 Concentration-dependent effects of GRFT on cellular viability.
The in vitro HIV-neutralizing activity of (a) OSGRFT, (b) ESGRFT and (c) wild-
type rice extracts against CEM-SS cells infected with HIV-1RF is presented
as cell viability relative to uninfected and untreated controls. Cell viability
was assessed using the XTT assay. All points are averages (SE) of
triplicate measurements.
Figure 6 (a) HIV-1 infectivity assay. TZM-bl cells were incubated with
serial dilutions of the extracts (in triplicate) and cultured for 72 h with HIV-
1BaL using a concentration optimized for infectivity. The extent of viral
replication was determined by measuring the luciferase activity of cell
lysates. Ordinate: Percentage of relative infection. Abscissa: Serial
dilutions. Results are shown as the percentage of infection relative to the
virus-only control  SE. (b) Effect of different concentrations of crude
extracts on cell viability. Cytotoxicity was determined using an MTT assay
and was expressed as the percentage of dead cells (mean  SD, n = 3).
Ordinate: Percentage relative viability. Abscissa: Serial dilutions. WT,
untransformed rice seed extract; C, negative (medium-only) control; C+,
cytotoxic positive control (nonoxynol-9).
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The number and nature of purification steps and the overall
cost of processing are key issues that determine the commercial
viability of recombinant proteins expressed in plants. Mori et al.
(2005) purified the native GRFT from Griffithsia spp. by ammo-
nium sulphate precipitation, hydrophobic interaction chromatog-
raphy, anion-exchange chromatography, reversed-phase
chromatography and size exclusion chromatography to yield a
homogeneous, highly pure and biologically active protein. We
found that ammonium sulphate precipitation did not work for
OSGRFT even when combined with ethanol precipitation. How-
ever, protein extraction using a phosphate buffer combined with
IMAC achieved 74% recovery and 80% purity. Giomarelli et al.
(2006) purified soluble ECGRFT by IMAC using Ni-NTA resin and
the dialysed protein was then applied to a TALON IMAC resin
before stepwise elution using two buffers containing different
amounts of imidazole, achieving 53% recovery. Ishag et al.
(2013) used IMAC followed by elution in a buffer containing
250 mM imidazole before further purification by size exclusion
chromatography using a Superdex 75 column. The resulting
purified protein contained both the monomeric and dimeric
forms of GRFT but the final purity and recovery were not
reported. Finally, Xue et al. (2013) used a nickel-chelating column
and eluted GRFT with 500 mM imidazole, refolding the protein by
dropwise addition to a low-salt refolding buffer before final
purification using C4 reversed-phase chromatography, but again
no data were reported for purity and recovery. When GRFT was
produced in N. benthamiana, the first purification step involved
the removal of the TMV vector coat protein by filtration through a
ceramic membrane, followed by ion-exchange chromatography
over SP-Sepharose resin, ultrafiltration/diafiltration to concentrate
the protein and elution with 100 mM NaCl, achieving >99.8%
purity albeit with only 30% recovery as stated above (O’Keefe
et al., 2009). We used nondenaturing conditions to prepare the
protein extract thus keeping GRFT in its native confirmation to
avoid the need for a refolding step. The protein was captured on
a Profinity IMAC column and eluted with 250 mM imidazole. This
is the first one-step purification procedure reported for GRFT, and
although the purity was lower than that reported by O’Keefe
et al. (2009), the use of rice as a production platform means that
stringent purity is unnecessary because the plant matrix is safe for
mucosal applications (Ning et al., 2008; Xie et al., 2008). The
large-scale production and purification of GRFT could be facili-
tated by exploiting its stability, because it remains soluble and
functional at temperatures up to ~80 °C, whereas most plant
host cell proteins precipitate below this temperature (Moulaei
et al., 2010; Ziołkowska et al., 2007b). Fuqua et al. (2015)
demonstrated that the purity of GRFT extracts can increase by
30%–40% at temperatures exceeding 50 °C, and using this
approach, they achieved a recovery rate of 88  5% compared
to the initial extract.
Immunoblotting using a primary rabbit anti-GRFT polyclonal
antiserum revealed a pair of intense bands, one migrating at
the anticipated molecular mass of 14.6 kDa and the other at
16–17 kDa. Because the gel was run under denaturing condi-
tions, the additional band is unlikely to represent a conforma-
tional isomer or the presence of a noncovalent binding partner.
It is possible that GRFT undergoes partial post-translational
modification and is therefore present in two forms, but the
GRFT sequence does not contain an N-glycan acceptor site so
only O-linked glycans would account for the difference in
mobility (2–3 kDa). A more likely explanation is the incomplete
removal of the rice a-amylase (RAmy3D) signal peptide, which
is 25 residues in length and has a predicted molecular mass of
2.6 kDa.
The deposition of GRFT in rice endosperm was studied by
fluorescence and electron microscopy. Our data confirmed that
GRFT is deposited predominantly in the PSVs, like other recom-
binant proteins expressed in cereal endosperm bearing a signal
peptide but no further targeting information. For example, a
recombinant fungal phytase was directed to the PSVs in rice and
wheat, and the HIV-neutralizing antibody 2G12 was deposited in
the PSVs of maize and rice (Arcalis et al., 2004; Drakakaki et al.,
2006; Peters et al., 2013; Vamvaka et al., 2015). Furthermore,
Drakakaki et al. (2006) described the presence of recombinant
phytase in ER-derived protein bodies, and the expression of
antibody 2G12 altered the morphology of zein bodies in maize
and induced the formation of novel ER-derived protein bodies in
rice (Peters et al., 2013; Vamvaka et al., 2015). In contrast, we
found that GRFT was localized almost exclusively in the PSVs and
could easily be extracted with PBS even though most of the
surrounding endogenous seed storage proteins are not soluble
under these conditions. The ability of GRFT to retain its
independent solubility suggests that it does not interact with
the storage proteins, for example by the formation of disulphide
bonds (Peters et al., 2013).
GRFT can interfere with the interaction between HIV and CD4+
cells by binding to the mannose-rich viral glycoproteins gp120,
gp41 and gp160, although it does not directly inhibit the binding
of gp120 to CD4 (Mori et al., 2005). GRFT interacts with a
number of viruses, but shows particular potency against HIV
because it can bind to multiple sites on gp120 (Giomarelli et al.,
2006). We therefore compared the biological activity of purified
OSGRFT, crude extracts containing OSGRFT and purified ECGRFT,
by testing their ability to bind gp120-IIIB in vitro. We found that
OSGRFT and ECGRFT bound to gp120 with near identical binding
characteristics and that the crude extracts showed similar binding
activity to the pure proteins once the concentration of GRFT in
the extracts was taken into account. Similarly, O’Keefe et al.
(2009) showed that N. benthamiana GRFT had similar or even
better gp120-binding activity than ECGRFT, which in turn retained
the gp120-binding activity of the native GRFT protein (Giomarelli
et al., 2002).
We also tested OSGRFT and ECGRFT head to head in whole-cell
HIV neutralization assays and found that both proteins achieved
near identical nanomolar EC50 values of 0.27 and 0.33 nM,
respectively, well within the range previously reported by Mori
et al. (2005). Crude extracts of wild-type rice endosperm showed
no activity against HIV. Giomarelli et al. (2006) showed that
ECGRFT inhibited HIV-induced cytopathicity with an EC50 value of
0.089 nM, similar to the EC50 value of native GRFT (0.163 nM) and
they concluded that both forms of GRFT were functionally
equivalent. However, O’Keefe et al. (2009) reported an EC50
value of 0.054 nM for native GRFT and 0.156 nM for tobacco-
derived GRFT. These discrepancies reflect the inherent variability
of the syncytium inhibition assay, which is suitable for compar-
isons within an experiment (where 2- to threefold differences are
not regarded as significant) but not across studies in different
laboratories, particularly when different HIV strains and assay
protocols are used (Forthal et al., 2010; Rademacher et al.,
2008).
Candidate microbicides must be tested for immunogenicity,
efficacy and safety before deployment, and in vitro cellular
models can be used to provide preliminary evidence for these
endpoints before progressing to ex vivo mucosal tissue explants,
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small animal models and nonhuman primates. The evaluation of
potential anti-HIV microbicides must consider the possibility of
immune cell stimulation, that is when producing a new version of
GRFT, it is important to rule out the ability of variants, process
contaminants and other impurities to provoke an immune
response. We found that OSGRFT did not stimulate the prolifer-
ation of the CEM-SS T-lymphocytic cell line used in the cytotox-
icity assays (Figure 5a) which at this stage provides confidence
that the product does not cause immune cell activation, although
further more detailed studies involving the analysis of cytokine
levels would be required during preclinical development.
There are several cell lines that are widely used to test the
efficacy of HIV microbicides, including PM-1 CD4+T cells (Lusso
et al., 1995) and the TZM-bl luciferase reporter cell line (Wei
et al., 2002). We carried out infectivity assays using TZM-bl cells,
which confirmed the potent activity of rice crude extracts
containing OSGRFT against HIV-1 and achieved almost 100%
prevention of infection. In terms of safety, cellular models are
used to assess the potential cytotoxicity of microbicides, often by
measuring the cleavage of a tetrazolium salt (MTT) into a blue-
coloured product (formazan) in viable cells (Slater et al., 1963).
We found that crude rice endosperm extracts at dilutions of 1/4
and higher showed no significant cytotoxicity against the TZM-bl
HeLa cervical epithelium cell line, suggesting that microbicides
based on crude rice endosperm extracts are unlikely to cause
cytotoxic effects when applied to mucosal surfaces. This result
confirms earlier studies with N. benthamiana-produced GRFT,
which confirmed its excellent safety profile (Kouokam et al.,
2011).
A commercially viable large-scale production platform for GRFT
must achieve adequate yields to meet demand, including the
recovery rate after purification, if relevant. The recovery of
recombinant proteins purified from rice can range from 1.8%
recovery with 95% purity to 55.8% recovery with more than
99.5% purity (Ou et al., 2014). Where high purity is not a major
requirement (i.e. when using crude extracts for topical applica-
tion), then the overall productivity of a rice production platform
can be calculated based on the techno-economic evaluation
presented by Nandi et al. (2002). Assuming grain yields of up to
8 ton/ha, at least 1.8 kg of OSGRFT could be harvested per
hectare, which is 4.5-fold higher than the ~0.4 kg/ha of GRFT
possible in N. benthamiana (O’Keefe et al., 2009) but lower than
6.6 kg/ha of pure CV-N produced in soybean seeds (O᾽Keefe
et al., 2015). Kaufman and Kalaitzandonakes (2011) have shown
that in order to scale up production to meet a demand of
1000 kg of purified recombinant protein per year, at least 550 ha
would be required assuming no losses, and nearly 950 ha would
be required to accommodate production risks of 20% and an
anticipated recovery rate of 75%.
The broad utility of OSGRFT in countries suffering the greatest
burden of HIV would also benefit from the absence of intellectual
property constraints. FTO analysis based on the simplified
procedure described by Miralpeix et al. (2014) revealed four key
patents covering GRFT-related technologies, two of which
potentially affect the commercial development of OSGRFT,
whereas the third is for chimeric proteins, protein combinations
and other compositions, and the fourth is limited to monomeric
GRFT and therefore does not affect the development of multi-
meric forms of the protein (Boyd et al., 2011; LiWang and
Kagiampakis, 2011; O’Keefe et al., 2011, 2014). The principal
claims made in these patents are summarized in Table S1.
Although we have demonstrated that rice is potentially a cost-
effective production platform for GRFT, the FTO analysis revealed
a possibility of patent infringement based on the GRFT sequence.
However, the United States National Institutes of Health (NIH),
which holds the most pertinent GRFT patents (Boyd et al., 2011,
2011; O’Keefe et al., 2011), has made the conscientious decision
not to patent GRFT-related technologies in developing countries
so as to allow these countries, many of them those most affected
by the HIV epidemic, to produce GRFT for use by their
populations without a licence. This strategy will make OSGRFT
available royalty free in developing countries (where it is needed
most), whereas conventional licensing options would be required
in the developed world (Kryder et al., 2000).
In conclusion, our data show that GRFT can be expressed in rice
endosperm with yields comparable to or higher than GRFT
produced by transient expression in N. benthamiana. Both the
crude extracts and the purified OSGRFT showed near identical
in vitro binding and HIV neutralization activity to ECGRFT,
confirming that OSGRFT is correctly folded in planta and remains
biologically active in the crude extracts and following purification.
The functionality of the crude and purified protein together with
the absence of cytotoxicity shows that rice could be developed as
a cost-effective production platform with minimal processing or
one-step purification strategies, thus offering the prospect of
inexpensive microbicides suitable for deployment in HIV-endemic
areas. Preliminary FTO and techno-economic analysis suggests
that OSGRFT could be commercially feasible using the humani-
tarian licensing strategy adopted by the NIH for developing
country applications and conventional licensing elsewhere.
Experimental procedures
Expression construct
The GRFT gene in vector pET-28a(+) was amplified by PCR in a
50 lL reaction containing 1.25 units of GoTaq polymerase in the
appropriate buffer (Promega, Madison, WI), 1 lM each of
forward primer 50-TGC ATG CAT GGG CAG CAG CCA TCA T-
30 and reverse primer 50-GGG GAG CTC TTA GTA CTG TTC ATA
GTA G-30 (the underlined nucleotides are SphI and SacI restriction
sites introduced to facilitate cloning), 0.2 mM of each dNTP and
250 ng template DNA. The reaction was heated to 94 °C for
3 min followed by 35 cycles of 94 °C for 45 s, 60 °C for 45 s and
72 °C for 3 min, followed by a final extension step at 72 °C for
10 min. The products were transferred to the shuttle vector
pGEM-T Easy (Promega) and introduced into competent E. coli
cells, which were incubated overnight at 37 °C under ampicillin
selection. The integrity of the plasmid DNA was confirmed by
sequencing (Universidad Autonoma de Barcelona, Spain) before
digestion with SphI and SacI to release the expression cassette,
which was then inserted into vector pgZ63 containing the
endosperm-specific maize zein promoter (Naqvi et al., 2009),
the rice a-amylase 3A signal peptide sequence (GenBank
CAA39776) and a sequence encoding a N-terminal His6 affinity
tag (Figure 1b).
Transformation and recovery of transgenic plants
Seven-day-old mature rice zygotic embryos (Oryza sativa cv.
Nipponbare) were transferred to osmotic medium (4.4 g/l
Murashige & Skoog (MS) powder supplemented with 0.3 g/l
casein hydrolysate, 0.5 g/l proline, 72.8 g/l mannitol and 30 g/l
sucrose) 4 h before bombardment with 10 mg gold particles
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coated with the GRFT construct and the selectable marker hpt at
a 3 : 1 ratio (Christou et al., 1991; Sudhakar et al., 1998; Valdez
et al., 1998). The embryos were returned to osmotic medium for
12 h before selection on MS medium (4.4 g/l MS powder, 0.3 g/l
casein, 0.5 g/l proline and 30 g/l sucrose) supplemented with
50 mg/l hygromycin and 2.5 mg/l 2,4-dichlorophenoxyacetic acid
in the dark for 2–3 weeks. Transgenic plantlets were regenerated
and hardened off in soil. Plants were grown in the greenhouse or
growth chamber at 28/20 °C day/night temperature with a 10-h
photoperiod and 60%–90% relative humidity for the first
50 days, followed by maintenance at 21/18 °C day/night tem-
perature with a 16-h photoperiod thereafter in a growth
chamber.
Enzyme-linked immunosorbent assay
The accumulation of GRFT in transgenic endosperm tissue was
confirmed by ELISA. Mature rice seeds were ground in three
volumes of PBS and centrifuged twice at 13 000 g for 10 min at
4 °C to remove debris. GRFT accumulation was confirmed by
coating the wells of ELISA plates with 100 ng recombinant gp120
from HIV-1 strain IIIB, provided by the MRC Centralized Facility for
AIDS Reagents, Potters Bar, UK. After washing and blocking with
2.5% bovine serum albumin (BSA) in PBS containing 0.1%
Tween-20 (PBST), serial dilutions of each seed extract were added
and protein assembly was confirmed using a primary rabbit anti-
GRFT polyclonal antiserum (The Binding Site, Birmingham, UK)
and a secondary horseradish peroxidase (HRP)-conjugated anti-
rabbit IgG antibody (The Binding Site), each diluted 1 : 1000. HRP
was detected by adding the substrate 3,30,5,50-tetramethylbenzi-
dine (TMB) (Sigma-Aldrich, St. Louis, MO) and reading the
absorbance at 450 nm.
Purification by affinity chromatography
Mature rice seeds were ground to a fine powder and extracted
overnight at 4 °C in five volumes of lysis buffer (50 mM NaH2PO4,
300 mM NaCl, 5 mM imidazole, pH 8). Insoluble material was
removed by centrifuging twice at 8000 g for 30 min at 4 °C.
Each sample was loaded onto a Profinity IMAC column at a flow
rate of 2 mL/min. The column was washed twice with wash
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8)
and the protein was eluted four times with elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8). Protein-
containing fractions were identified using a NanoDrop 2000c UV-
Vis spectrophotometer (Thermo Fisher Scientific, Waltham, MA)
based on extinction coefficient at 280 nm of the protein, and
GRFT concentrations were determined by ELISA (see above).
Fractions containing >50 lg/mL GRFT were pooled and concen-
trated by ultrafiltration using spin columns with a 3 kDa
molecular weight cut-off (Amicon Ultra, EMD Millipore, Darm-
stadt, Germany).
SDS-PAGE and immunoblotting
The efficiency of protein purification was tested by SDS-PAGE in
4–12% precast Bis-Tris NuPAGE gels (Invitrogen, Carlsbad, CA)
using Precision Plus Protein Standards (Bio-Rad, Hercules). Each
sample comprised 5 lL of rice seed extract and 5 lL SDS loading
buffer (0.3 M Tris-HCl pH 6.8, 10% (w/v) SDS, 50% (v/v) glycerol,
0.125% (w/v) bromophenol blue). For immunoblotting, samples
were transferred to nitrocellulose membranes using the Hoefer
TE70 semidry transfer system (Amersham Biosciences, Piscat-
away, NJ) and blocked with 5% nonfat dried milk in Tris-buffered
saline (TBS) (50 mM Tris, 150 mM NaCl, pH 7.6). After three
washes with TBS containing 0.1% Tween-20 (TBST), protein
expression was confirmed using the primary rabbit anti-GRFT
polyclonal antiserum and a secondary HRP-conjugated anti-rabbit
IgG antiserum described above, each diluted 1 : 1000. The signal
was detected using the ECL Plus Western Blotting Detection
System (GE Healthcare, Amersham, Little Chalfont, UK).
In vitro gp120-binding assay
The specific antigen-binding activity of GRFT was determined by
coating the wells of ELISA plates with 100 ng recombinant gp120
from HIV-1 strain IIIB, provided by the MRC Centralized Facility for
AIDS Reagents, Potters Bar, UK. After washing with PBST and
blocking with 2.5% BSA in PBST, serial dilutions of the GRFT
protein were added and the amount of bound protein deter-
mined using a primary rabbit anti-GRFT polyclonal antiserum and
secondary HRP-conjugated anti-rabbit IgG antiserum diluted
1 : 1000. The signal was developed with TMB substrate and
the absorbance was read at 450 nm.
Microscopy
Immature rice seeds (15–20 days after pollination) from wild-type
plants and transgenic line 6 were fixed and processed for
microscopy as previously described (Arcalis et al., 2004). Briefly,
1 mm3 seed fragments were fixed in 4% (w/v) paraformaldehyde
and 0.5% (v/v) glutaraldehyde in 0.1 M phosphate buffer (pH
7.4) overnight at 4 °C, then dehydrated through an ethanol series
and infiltrated in LR White resin before polymerization at 60 °C.
We prepared 1-lm sections for fluorescence microscopy, and
ultrathin sections showing silver interference were used for TEM.
The sections were incubated with a polyclonal rabbit anti-GRFT
antibody and secondary antibodies labelled with Alexa Fluor 488
for fluorescence microscopy or 10-nm gold particles for electron
microscopy. The sections were analysed on a Leica DM5500B
fluorescence microscope and a FEI Tecnai G2 electron microscope
operating at 160 kV.
Whole-cell HIV neutralization assays
Whole-cell HIV neutralization assays were carried out using the
2,3-bis-[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carbox-
anilide inner salt (XTT) tetrazolium system. The HIV-neutralizing
activities of ECGRFT and OSGRFT were compared in CEM-SS cells
challenged with HIV-1RF (Gulakowski et al., 1991). XTT was
provided by the Drug Synthesis and Chemistry Branch, Develop-
mental Therapeutics Program, Division of Cancer Treatment and
Diagnosis, National Cancer Institute. CEM-SS cells were main-
tained in RPMI 1640 medium without phenol red and supple-
mented with 5% foetal bovine serum, 2 mM L-glutamine and
50 lg/mL gentamicin (BioWhittaker). Exponentially growing cells
were washed and resuspended in complete medium, and a 50-lL
aliquot containing 5 9 103 cells was added to individual wells of
a 96-well round-bottomed microtiter plate containing serial
dilutions of ECGRFT or OSGRFT in 100 lL medium. Stock super-
natants of HIV-1RF were diluted in complete medium to yield
sufficient cytopathicity (80%–90% cell death in 6 days), and a
50-lL aliquot was added to the appropriate wells. Additional
control wells did not receive viral challenge so as to measure any
compound-induced effect on cell growth. Plates were incubated
for 6 days at 37 °C and then stained with XTT to detect viable
cells. The resulting data display both the protection of cells from
the cytopathic effects of HIV-1 and any direct cytotoxic effects of
the test compounds on CEM-SS cells. All experiments were
carried out in triplicate.
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Cell and virus culture
TZM-bl cells (NIH AIDS Reagent Program), a HeLa cell line
expressing CD4, CCR5 and luciferase (Platt et al., 2009), were
grown in continual culture in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% foetal calf serum, 100 U/mL
penicillin, 100 lg/mL streptomycin and 2 mM L-glutamine. HIV-
1BaL (R5) was grown in PM-1 CD4+ T cells. Cell free viral stocks
were passed through 0.2-lm filters.
Cytotoxicity and antiviral assays
The viability of cells following exposure to rice seed crude extracts
as well as the cytotoxicity of the crude extracts was assessed using
the MTT colorimetric assay as previously described (Mesquita
et al., 2008). Crude extracts of wild-type and transgenic rice
endosperm expressing OSGRFT were diluted to 50% concentra-
tion; then, a twofold serial dilution was performed. TZM-bl cells
(105/well) were cultured in the presence of extracts for 24 h at
37 °C and titrated in triplicate onto 105 TZM-bl cells per well.
Twofold serial dilutions of the extracts were prepared for testing,
and nonoxynol-9 was used as a positive control for cytotoxicity.
Viability was determined by measurement of formazan produc-
tion in cell lysates. Results were expressed as the percentage of
cellular viability attained compared to the negative, media-only
control, plus or minus the standard deviation (SD). Results were
expressed as the percentage of cellular viability compared to the
negative (medium-only) control  standard deviation (SD).
To investigate any potential antiviral activity of the same crude
extracts, the luciferase assaywas performedas previously described
(Madan et al., 2007). Extracts were diluted to 50% concentration;
then, a twofold serial dilution was performed. TZM-bl cells (104/
well) were cultured in the presence of extracts for 72 h at 37 °C
with a concentration of HIV-1BaL optimized for infectivity. The
extent of viral replication was determined by the quantification of
luciferase on cell lysates (Promega, Madison, WI). Results were
presented as the percentage of infection attained relative to the
virus-only control, plus or minus the standard error (SE). To
determine the antiviral potency of the same crude extracts, they
were titrated onto TZM-bl cells (104 cells well) in triplicate and
cultured for 72 h with HIV-1BaL using a concentration optimized
for infectivity. Twofold serial dilutions of the extractswere prepared
for testing. The extent of viral replication was determined by
measuring luciferase activity in the cell lysates using a luciferase
assay system (Promega, UK) as described by Wei et al. (2002).
Resultswere expressed as the percentage of infection relative to the
virus-only control  standard error (SE).
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